Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$335M |
| 2 |
Exelon
EXC
|
+$314M |
| 3 |
Procter & Gamble
PG
|
+$241M |
| 4 |
TripAdvisor
TRIP
|
+$208M |
| 5 |
Starbucks
SBUX
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$551M |
| 2 |
Target
TGT
|
+$514M |
| 3 |
CELG
Celgene Corp
CELG
|
+$495M |
| 4 |
Cigna
CI
|
+$369M |
| 5 |
Costco
COST
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.21% |
| 2 | Healthcare | 19.58% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Industrials | 9.29% |
| 5 | Financials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.59T
| $2.11B | 2.23% |
17,976,511
-2,196,267
| -11% | -$240M |
|
2
Apple
AAPL
$4.51T
| $1.57B | 1.67% |
33,344,284
-443,404
| -1% | -$18.8M |
|
|
3
Exelon
EXC
$45.1B
| $1.22B | 1.29% |
34,124,160
+9,207,892
| +37% | +$314M |
|
4
Amazon
AMZN
$2.79T
| $1.08B | 1.14% |
12,091,820
-308,880
| -2% | -$25.7M |
|
5
Pfizer
PFE
$160B
| $1.05B | 1.11% |
26,184,416
-2,530,775
| -9% | -$101M |
|
6
Meta Platforms (Facebook)
META
$1.4T
| $1.04B | 1.11% |
6,316,808
-523,771
| -8% | -$83.3M |
|
7
Merck
MRK
$376B
| $1.04B | 1.1% |
13,117,502
-589,049
| -4% | -$44.1M |
|
|
8
Biogen
BIIB
$32B
| $992M | 1.05% |
4,219,856
+1,063,775
| +34% | +$335M |
|
9
Johnson & Johnson
JNJ
$651B
| $890M | 0.94% |
6,363,319
-283,722
| -4% | -$38M |
|
10
Intel
INTC
$476B
| $853M | 0.91% |
15,920,358
-2,250,090
| -12% | -$114M |
|
11
Alphabet (Google) Class A
GOOGL
$4.22T
| $822M | 0.87% |
14,078,540
-267,340
| -2% | -$15.1M |
|
12
Cisco
CSCO
$438B
| $799M | 0.85% |
14,953,902
+1,162,437
| +8% | +$56.5M |
|
13
Micron Technology
MU
$1.09T
| $796M | 0.84% |
19,417,053
-3,435,881
| -15% | -$133M |
|
14
Adobe
ADBE
$109B
| $770M | 0.82% |
2,899,828
-815,490
| -22% | -$206M |
|
15
Elevance Health
ELV
$86.9B
| $740M | 0.79% |
2,613,087
-349,974
| -12% | -$101M |
|
16
Alibaba
BABA
$286B
| $717M | 0.76% |
3,929,533
-65,347
| -2% | -$11M |
|
17
Verizon
VZ
$205B
| $673M | 0.71% |
11,430,304
+9,112
| +0.1% | +$516K |
|
|
18
Procter & Gamble
PG
$336B
| $631M | 0.67% |
6,066,641
+2,474,028
| +69% | +$241M |
|
19
Intuit
INTU
$100B
| $616M | 0.65% |
2,369,984
+64,534
| +3% | +$14.9M |
|
20
Humana
HUM
$45.5B
| $611M | 0.65% |
2,323,541
-395,305
| -15% | -$114M |
|
21
Consolidated Edison
ED
$39.3B
| $582M | 0.62% |
6,882,799
-417,513
| -6% | -$33.4M |
|
22
Gilead Sciences
GILD
$181B
| $582M | 0.62% |
8,956,479
+285,954
| +3% | +$19M |
|
23
Allstate
ALL
$64.2B
| $582M | 0.62% |
6,193,571
-2,111,082
| -25% | -$191M |
|
24
HF Sinclair
DINO
$17.3B
| $580M | 0.62% |
11,776,317
+1,753,888
| +17% | +$93.4M |
|
|
RTN
25
DELISTED
Raytheon Company
RTN
| $540M | 0.57% |
2,975,477
-1,306,132
| -31% | -$228M |
|
Similar funds
Cliff Asness's Q1 2019 Portfolio in Review
As of Q1 2019, Cliff Asness held 2,315 positions worth $94.3B, up 9.2% from $86.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness's Q1 2019 filing shows 140 new, 934 increased, 1,002 reduced and 155 closed positions. Its largest new stake was Canopy Growth: 121,700 shares worth $52.7M. The largest sale was Walmart Inc, an estimated $551M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Cliff Asness's largest Q1 2019 buy was Canopy Growth: 121,700 shares worth $52.7M.
- Cliff Asness added most to Biogen in Q1 2019, an estimated $335M increase.
- Cliff Asness's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $551M.
- Cliff Asness fully exited Dun & Bradstreet in Q1 2019, selling an estimated $74.4M.
- Cliff Asness's ten largest holdings make up 13% of its $94.3B portfolio in Q1 2019.
- Cliff Asness opened 140 new positions and closed 155 in Q1 2019.
- Cliff Asness's portfolio value rose 9.2% quarter-over-quarter to $94.3B.
Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.